Coherus BioSciences | Chart & Forecast SummaryKey Indicators On Trade Set Up In General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Notes On Session
# Coherus BioSciences
- Double Formation
* Support=0 | EMA 20 | Area DIsclosure | Subdivision 1
* Neckline | Pattern Alignment At 2.40
- Triple Formation
* Entry Bias Hypothesis | Entr
CHRS - upcoming catalyst - breakout ahead ?Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-appro
Junshi Biosciences and Coherus Announce Positive Interim OverallCHRS: Junshi Biosciences
2021-12-13 07:00:00
Junshi Biosciences and Coherus Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
COHERUS cracking $21 will unleash major bullish potentialCOHERUS BIOSCIENCES Inc., NASDAQ:CHRS , is a bioscience company that has not yet not benefited from the sector's outperformance despite significantly improving financials and the business becoming profitable. When the stock price cracks the $21 level it will unlock a significant bullish potential.
CHRS, Stochastic Oscillator left the overbought zone on Oct 09This is a signal that CHRS's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position. Tickeron A.I.dvisor identified 63 similar cases where CHRS's stochastic oscillator exited the overbought zone, and 58 of them led to successful outcomes. Odds of
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.